Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -5585.1% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 128.4 | n/a |
Pr/Book | 7.6 |
Latest | F'cast | |
---|---|---|
Revenue | -54.8% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-18 | 1.19 | (2.42) | (2.20)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-19 | 0.91 | (3.39) | (3.00)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-20 | 0.46 | (4.95) | (4.70)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-21 | 0.34 | (7.63) | (7.20)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-22 | 0.15 | (7.57) | (6.70)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Half-year Report | 30-May-2023 | 07:00 | RNS |
Notice of Interim Results and Investor Webinar | 16-May-2023 | 07:00 | RNS |
CiRT expanded validation for ICI immunotherapies | 15-May-2023 | 07:00 | RNS |
Oxford Biodynamics first-half losses widen | 30-May-2023 | ShareCast |
Oxford Biodynamics raises £9.1m in placing | 07-Oct-2022 | ShareCast |
Oxford BioDynamics awarded $0.91m US PACT grant | 31-Aug-2021 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 13.48p |
Change Today | -0.33p |
% Change | -2.36 % |
52 Week High | 22.00 |
52 Week Low | 11.25 |
Volume | 187,509 |
Shares Issued | 146.71m |
Market Cap | £19.77m |
Value | ![]() |
---|
Price Trend | ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
17:08 | 20,000 @ 13.48p |
16:28 | 27,578 @ 13.78p |
15:26 | 1,353 @ 13.37p |
13:06 | 29,574 @ 13.60p |
13:05 | 426 @ 13.60p |
You are here: research